Obstetrics, Gynaecology and Reproductive Medicine
Volume 17, Issue 6 , Pages 169-172, June 2007

Endometrial hyperplasia:

a clinician's review

Abstract 

Endometrial hyperplasia is defined as an increase in the glandular to stromal tissue ratio to more than 1. Further classification derives from architectural and cytological features. It typically results from excess or unopposed oestrogenic stimulation. Although it is often asymptomatic, endometrial hyperplasia can present with abnormal uterine bleeding. Transvaginal ultrasonography (to measure endometrial thickness), endometrial sampling and hysteroscopy are common investigations used to diagnose this condition. Management depends on cellular atypia, the presence of which confers a high risk of concurrent or subsequent endometrial cancer. Such cases should usually therefore be treated with hysterectomy. The absence of atypia allows a conservative approach, usually with progestogen therapy combined with ongoing surveillance.

Keywords: endometrial hyperplasia, post-menopausal bleeding, endometrial cancer, oestrogen

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1751-7214(07)00082-6

doi:10.1016/j.ogrm.2007.04.006

Obstetrics, Gynaecology and Reproductive Medicine
Volume 17, Issue 6 , Pages 169-172, June 2007